Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirogabalin in Japanese patients with DPNP or PHN and renal impairment
NCT02607280Phase 3Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Dec 2015
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mirogabalin in diabetic polyneuropathy (DPN), postherpetic neuralgia (PHN), sponsored by Daiichi Sankyo Co., Ltd.. Started Dec 2015; status: completed.
02
Drugs
mirogabalin
03
Conditions
diabetic polyneuropathy (DPN)postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT02607280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02607280.